- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Factors implicated in radiation therapy failure and radiosensitization of prostate cancer - Abstract
February 2, 2012
Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model - Abstract
February 2, 2012
Prognostic determinants in prostate cancer - Abstract
February 2, 2012
Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer - Abstract
February 2, 2012
α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth - Abstract
February 2, 2012
Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness - Abstract
February 2, 2012
The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy - Abstract
February 1, 2012
Optimal baseline prostate-specific antigen level to distinguish risk of prostate cancer in healthy men between 40 and 69 years of age - Abstract
February 1, 2012
Treatment given near the end of life in castration-resistant prostate cancer - Abstract
February 1, 2012
Lymph node staging with choline PET/CT in patients with prostate cancer: A review - Abstract
February 1, 2012
Paraneoplastic neurological and hematological syndromes associated with prostate cancer - Abstract
February 1, 2012
Evaluation of clinical benefits achievable by using different optimization algorithms during real-time prostate brachytherapy - Abstract
February 1, 2012
Open vs. robotic-assisted radical prostatectomy: A single surgeon and pathologist comparison of pathologic and oncologic outcomes - Abstract
February 1, 2012